Table 2.
Univariate analysis for hematoma expansion and poor outcome in the 3–10 ml subgroup
| HE (n = 251) | Poor outcome (n = 251) | |||||
|---|---|---|---|---|---|---|
| HE (n = 28) | NHE (n = 223) | p value | Poor outcome (n = 143) | Favorable outcome (n = 108) | p value | |
| Age, y, mean (SD) | 61.3 (10.6) | 63.0 (12.1) | 0.467 | 63.7 (11.3) | 61.6 (12.7) | 0.180 |
| Male | 18 (64.3) | 126 (56.5) | 0.432 | 77 (53.8) | 67 (62.0) | 0.201 |
| Arterial hypertension | 24 (85.7) | 191 (87.2) | 0.768 | 122 (87.8) | 93 (86.1) | 0.700 |
| Diabetes mellitus | 6 (21.4) | 37 (16.9) | 0.596 | 25 (18.0) | 18 (16.7) | 0.786 |
| ICH | 1 (3.6) | 8 (3.7) | 1 | 4 (2.9) | 5 (4.6) | 0.510 |
| Ischemic stroke | 2 (7.1) | 16 (7.3) | 1 | 12 (8.6) | 6 (5.6) | 0.356 |
| IVH | 7 (25) | 90 (40.4) | 0.116 | 58 (40.6) | 39 (36.1) | 0.474 |
| Black hole sign | 5 (17.9) | 12 (5.4) | 0.029 | 14 (9.8) | 3 (2.8) | 0.029 |
| Blend sign | 4 (14.3) | 8 (3.6) | 0.033 | 6 (4.2) | 6 (5.6) | 0.617 |
| Island sign | 2 (7.1) | 8 (3.6) | 0.309 | 9 (6.3) | 1 (0.9) | 0.047 |
| Satellite sign | 8 (28.6) | 38 (17) | 0.137 | 31 (21.7) | 15 (13.9) | 0.114 |
| Location | 1 | 0.001 | ||||
| Deep | 24 (85.7) | 188 (84.3) | 130 (90.9) | 82 (75.9) | ||
| Other | 4 (14.3) | 35 (15.7) | 13 (9.1) | 26 (24.1) | ||
| Hematoma volume, ml, mean (SD) | 7.5 (1.9) | 6.7 (2.0) | 0.034 | 6.8 (2.0) | 6.7 (2.0) | 0.699 |
| Time from onset to CT, h, mean (SD) | 2.5 (1.4) | 3.1 (1.5) | 0.055 | 2.9 (1.4) | 3.2 (1.5) | 0.170 |
| Admission GCS score, median (IQR) | 14(9–15) | 15 (13–15) | 0.009 | 14 (11–15) | 15 (15–15) | <0.001 |
| R-score, median (IQR) | −1.391 (−1.932–−1.108) | −2.247 (−3.114–−1.421) | <0.001 | −1.968 (−2.749–−1.288) | −2.382 (−3.257–−1.427) | 0.024 |
GCS, Glasgow coma scale; HE, Hematoma expansion; ICH, Intracerebral hemorrhage; IQR, Interquartile range; IVH, Intraventricular hemorrhage; NHE, Non-hematoma expansion; R-score, Radiomic score; SD, Standard deviation.
All values are presented as count (%), unless otherwise specified.